Partial Depletion of Microglia Attenuates Long-Term Potentiation Deficits Following Repeated Blast Traumatic Brain Injury in Organotypic Hippocampal Slice Cultures

Overview

Journal J Neurotrauma

Publisher Mary Ann Liebert

Specialties Emergency Medicine
Neurology

Date 2022 Dec 12

PMID 36508265

Authors

Nevin Varghese

Barclay Morrison 3rd

Affiliations

Soon will be listed here.

Abstract

Blast-induced traumatic brain injury (bTBI) has been a health concern in both military and civilian populations due to recent military and geopolitical conflicts. Military service members are frequently exposed to repeated bTBI throughout their training and deployment. Our group has previously reported compounding functional deficits as a result of increased number of blast exposures. In this study, we further characterized the decrease in long-term potentiation (LTP) by varying the blast injury severity and the inter-blast interval between two blast exposures. LTP deficits were attenuated with increasing inter-blast intervals. We also investigated changes in microglial activation; expression of CD68 was increased and expression of CD206 was decreased after multiple blast exposures. Expression of macrophage inflammatory protein (MIP)-1α, interleukin (IL)-1β, monocyte chemoattractant protein (MCP)-1, interferon gamma-inducible protein (IP)-10, and regulated on activation, normal T cell expressed and secreted (RANTES) increased, while expression of IL-10 decreased in the acute period after both single and repeated bTBI. By partially depleting microglia prior to injury, LTP deficits after injury were significantly reduced. Treatment with the novel drug, MW-189, prevented LTP deficits when administered immediately following a repeated bTBI and even when administered only for an acute period (24 h) between two blast injuries. These findings could inform the development of therapeutic strategies to treat the neurological deficits of repeated bTBI suggesting that microglia play a major role in functional neuronal deficits and may be a viable therapeutic target to lessen the neurophysiological deficits after bTBI.

References

Csuka E, Morganti-Kossmann M, Lenzlinger P, Joller H, Trentz O, Kossmann T . IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: relationship to IL-6, TNF-alpha, TGF-beta1 and blood-brain barrier function. J Neuroimmunol. 1999; 101(2):211-21. DOI: 10.1016/s0165-5728(99)00148-4. View

Utagawa A, Truettner J, Dietrich W, Bramlett H . Systemic inflammation exacerbates behavioral and histopathological consequences of isolated traumatic brain injury in rats. Exp Neurol. 2008; 211(1):283-91. PMC: 2435258. DOI: 10.1016/j.expneurol.2008.02.001. View

Ito D, Imai Y, Ohsawa K, Nakajima K, Fukuuchi Y, Kohsaka S . Microglia-specific localisation of a novel calcium binding protein, Iba1. Brain Res Mol Brain Res. 1998; 57(1):1-9. DOI: 10.1016/s0169-328x(98)00040-0. View

Kumar R, Rubin J, Berger R, Kochanek P, Wagner A . Principal components derived from CSF inflammatory profiles predict outcome in survivors after severe traumatic brain injury. Brain Behav Immun. 2015; 53:183-193. PMC: 4783208. DOI: 10.1016/j.bbi.2015.12.008. View

Del Rey A, Balschun D, Wetzel W, Randolf A, Besedovsky H . A cytokine network involving brain-borne IL-1β, IL-1ra, IL-18, IL-6, and TNFα operates during long-term potentiation and learning. Brain Behav Immun. 2013; 33:15-23. DOI: 10.1016/j.bbi.2013.05.011. View

Witkowski E, Gao Y, Gavsyuk A, Maor I, DeWalt G, Eldred W . Rapid Changes in Synaptic Strength After Mild Traumatic Brain Injury. Front Cell Neurosci. 2019; 13:166. PMC: 6498971. DOI: 10.3389/fncel.2019.00166. View

Bohlen C, Bennett F, Tucker A, Collins H, Mulinyawe S, Barres B . Diverse Requirements for Microglial Survival, Specification, and Function Revealed by Defined-Medium Cultures. Neuron. 2017; 94(4):759-773.e8. PMC: 5523817. DOI: 10.1016/j.neuron.2017.04.043. View

Kwon S, Kovesdi E, Gyorgy A, Wingo D, Kamnaksh A, Walker J . Stress and traumatic brain injury: a behavioral, proteomics, and histological study. Front Neurol. 2011; 2:12. PMC: 3057553. DOI: 10.3389/fneur.2011.00012. View

Keselman H, Cribbie R, Holland B . Controlling the rate of Type I error over a large set of statistical tests. Br J Math Stat Psychol. 2002; 55(Pt 1):27-39. DOI: 10.1348/000711002159680. View

10.

Lund S, Christensen K, Hedtjarn M, Mortensen A, Hagberg H, Falsig J . The dynamics of the LPS triggered inflammatory response of murine microglia under different culture and in vivo conditions. J Neuroimmunol. 2006; 180(1-2):71-87. DOI: 10.1016/j.jneuroim.2006.07.007. View

11.

Vitkovic L, Bockaert J, Jacque C . "Inflammatory" cytokines: neuromodulators in normal brain?. J Neurochem. 2000; 74(2):457-71. DOI: 10.1046/j.1471-4159.2000.740457.x. View

12.

Susaki E, Tainaka K, Perrin D, Yukinaga H, Kuno A, Ueda H . Advanced CUBIC protocols for whole-brain and whole-body clearing and imaging. Nat Protoc. 2015; 10(11):1709-27. DOI: 10.1038/nprot.2015.085. View

13.

Fujita M, Wei E, Povlishock J . Intensity- and interval-specific repetitive traumatic brain injury can evoke both axonal and microvascular damage. J Neurotrauma. 2012; 29(12):2172-80. PMC: 3419839. DOI: 10.1089/neu.2012.2357. View

14.

Willis E, MacDonald K, Nguyen Q, Garrido A, Gillespie E, Harley S . Repopulating Microglia Promote Brain Repair in an IL-6-Dependent Manner. Cell. 2020; 180(5):833-846.e16. DOI: 10.1016/j.cell.2020.02.013. View

15.

Van Eldik L, Sawaki L, Bowen K, Laskowitz D, Noveck R, Hauser B . First-in-Human Studies of MW01-6-189WH, a Brain-Penetrant, Antineuroinflammatory Small-Molecule Drug Candidate: Phase 1 Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Studies in Healthy Adult Volunteers. Clin Pharmacol Drug Dev. 2020; 10(2):131-143. PMC: 7541708. DOI: 10.1002/cpdd.795. View

16.

Rusiecki J, Levin L, Wang L, Byrne C, Krishnamurthy J, Chen L . Blast traumatic brain injury and serum inflammatory cytokines: a repeated measures case-control study among U.S. military service members. J Neuroinflammation. 2020; 17(1):20. PMC: 6958571. DOI: 10.1186/s12974-019-1624-z. View

17.

Tan Y, Yuan Y, Tian L . Microglial regional heterogeneity and its role in the brain. Mol Psychiatry. 2019; 25(2):351-367. PMC: 6974435. DOI: 10.1038/s41380-019-0609-8. View

18.

Nenov M, Malkov A, Konakov M, Levin S . Interleukin-10 and transforming growth factor-β1 facilitate long-term potentiation in CA1 region of hippocampus. Biochem Biophys Res Commun. 2019; 518(3):486-491. DOI: 10.1016/j.bbrc.2019.08.072. View

19.

Gama Sosa M, De Gasperi R, Perez Garcia G, Sosa H, Searcy C, Vargas D . Lack of chronic neuroinflammation in the absence of focal hemorrhage in a rat model of low-energy blast-induced TBI. Acta Neuropathol Commun. 2017; 5(1):80. PMC: 6389215. DOI: 10.1186/s40478-017-0483-z. View

20.

Effgen G, Hue C, Vogel 3rd E, Panzer M, Meaney D, Bass C . A Multiscale Approach to Blast Neurotrauma Modeling: Part II: Methodology for Inducing Blast Injury to in vitro Models. Front Neurol. 2012; 3:23. PMC: 3285773. DOI: 10.3389/fneur.2012.00023. View